Skip to main content
SpringerLink
Log in

Bildgesteuerte, minimalinvasive Verfahren in der Onkologie

  • Topic
  • Published:
best practice onkologie Aims and scope

Zusammenfassung

Neben der klassischen, systemischen Chemotherapie und der Tumorchirurgie hat sich eine Vielzahl bildgesteuerter, minimalinvasiver Verfahren etabliert. Ihnen gemein ist ein hoher, lokaler Effekt ohne die charakteristischen Nebenwirkungen der Standardverfahren. Prinzipiell kann zwischen perkutan ablativen, transarteriellen und nichtinvasiven Verfahren differenziert werden. Sämtliche Verfahren lassen sich nahezu ubiquitär einsetzen. Sie haben aber zurzeit ihre überragende Bedeutung bei der Behandlung tumoröser Prozesse der Leber. Im Folgenden stellen wir die Grundprinzipien der wichtigsten Verfahren vor und diskutieren deren methodische Vor- und Nachteile. Strahlentherapeutische oder nuklearmedizinische Verfahren sind nicht Gegenstand dieses Artikels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb.1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Vallo S, Eichler K, Kelly K et al (2014) MR-guided laser-induced thermotherapy in ex vivo porcine kidney: comparison of four different imaging sequences. Lasers Surg Med 46(7):558–562

    Article  PubMed  Google Scholar 

  2. Livraghi T, Bolondi L, Lazzaroni S et al (1992) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 69(4):925–929

    Article  CAS  PubMed  Google Scholar 

  3. Orlando A, Leandro G, Olivo M et al (2009) Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 104(2):514–524

    Article  PubMed  Google Scholar 

  4. Pompili M, Pacella CM, Francica G et al (2010) Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. Eur J Radiol 74(3):e6–e11

    Article  PubMed  Google Scholar 

  5. McGahan JP, Brock JM, Tesluk H et al (1992) Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 3(2):291–297

    Article  CAS  PubMed  Google Scholar 

  6. Ward RC, Healey TT, Dupuy DE (2013) Microwave ablation devices for interventional oncology. Expert Rev Med Devices 10(2):225–238

    Article  CAS  PubMed  Google Scholar 

  7. Kim SK, Lim HK, Ryu JA et al (2004) Radiofrequency ablation of rabbit liver in vivo: effect of the Pringle maneuver on pathologic changes in liver surrounding the ablation zone. Korean J Radiol 5(4):240–249

    Article  PubMed Central  PubMed  Google Scholar 

  8. Livraghi T, Solbiati L, Meloni MF et al (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226(2):441–451

    Article  PubMed  Google Scholar 

  9. Carrafiello G, Lagana D, Ianniello A et al (2007) Post-radiofrequency ablation syndrom after percutaneous radiofrequency of abdominal tumors: one centre experience and review of published works. Australas Radiol 51(6):550–554

    Article  CAS  PubMed  Google Scholar 

  10. Snoeren N, Huiskens J, Rijken AM et al (2011) Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor regression. Ann Surg Oncol 18(13):3702–3710

    Article  PubMed Central  PubMed  Google Scholar 

  11. Ng KM, Chua TC, Saxena A et al (2011) Two decades of experience with hepatic cryotherapy for advanced colorectal metastases. Ann Surg Oncol 19(4):1276–1283

    Article  PubMed  Google Scholar 

  12. Leitlinienprogramm Onkologie. Diagnostik und Therapie des hepatozellulären Karzinom. AWMF-Registernummer 032/0530l. Mai 2013

  13. Leitlinie RFA (Perkutane bildgesteuerte Leber-Tumortherapie mittels Radiofrequenz-Ablation) - Deutsche Gesellschaft für Interventionelle Radiologie (zurzeit in Überarbeitung).

  14. Maintz D, Köhler M, Bangard C (2012) Minimal invasive interventionelle Verfahren bei kolorektalen Lebermetastasen. Viszeralmedizin 28:34–42

    Article  Google Scholar 

  15. Van Duijnhoven FH, Jansen MC, Junggeburt JM et al (2006) Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 13(5):651–658

    Article  PubMed  Google Scholar 

  16. Vogel TJ, Zangos S, Scholtz JE et al (2014) Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two european centers. RöFo 186:937–944

    Google Scholar 

  17. Kemeny NE, Melendez FDH, Capanu M et al (2009) Conversion to resectability using hepatic artery infusion plus systemic chemotherapy fort he treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 27:3465–3471

    Article  PubMed Central  PubMed  Google Scholar 

  18. Llovet JM, Bruix J (2003) Systematic reviews of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37(2):429–442

    Article  CAS  PubMed  Google Scholar 

  19. Dumortier J, Chapuis F, Borson O (2006) Unresectable hepatocellular carcinoma: Survival and prognostic factors after lipiodol chemoembolisation in 89 patients. Dig Liver Dis 38:125–133

    CAS  PubMed  Google Scholar 

  20. Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41–50

    Article  PubMed Central  PubMed  Google Scholar 

  21. Song MJ, Park C-H, KIM JD et al (2011) Drug-eluting bead loaded with doxorubicin versus conventional lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients. Eur J Gastroenterol Hepatol 23:521–527

    Article  CAS  PubMed  Google Scholar 

  22. Martin RC, Robbins K, Tomalty D et al (2009) Transarterial chemoembolization (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 7:80

    Article  PubMed Central  PubMed  Google Scholar 

  23. Moll R, Schindler G (2009) Komplikationen und Nebenwirkungen bei der TACE des HCC. RöFo 181(Suppl I) VO: 406

    Google Scholar 

  24. Pieper CC, Meyer C, Vollmar B et al (2014) Temporary arterial embolization of liver parenchyma with degradable starch microspheres (EmboCept®S) in a swine model. Cardiovasc Intervent Radiol 2014 Aug 20 [Epub ahead of print]

    Google Scholar 

  25. Pfeifle CE, Howell SB, Ashburn WL et al (1986) Pharmacologic studies of intra-hepatic artery chemotherapy with degradable starch microspheres. Cancer Drug Deliv 3(1):1–14

    Article  CAS  PubMed  Google Scholar 

  26. Van de Wiele C, Maes A, Brugman E et al (2012) SIRT of liver metastases: physiological and pathophysiological considerations. Eur J Nucl Med Mol Imaging 39(10):1646–1655

    Article  PubMed  Google Scholar 

  27. Yip D, Allen R, Ashton C et al (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349

    Article  PubMed  Google Scholar 

  28. Sarfaraz M, Kennedy AS, Cao ZJ et al (2003) Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30:199–203

    Article  CAS  PubMed  Google Scholar 

  29. Young JY, Rhee TK, Atassi B et al (2007) Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol 18:1375–1382

    Article  PubMed  Google Scholar 

  30. Park JW, Amarapurkar D, Chao Y et al (2013) Consensus recommendations and review by an international expert panel on interventions in hepatocellular carcinoma (EPOIHCC). Liver Int 33(3):327–337

    Article  CAS  PubMed  Google Scholar 

  31. Erhardt A, Kolligs FT, Dollinger E et al (2011) TACE plus sorafenib for the treatment of hepatocellular carcinoma: final results of the multicenter SOCRATES trial. J Clin Oncol 29 (suppl): abstr 4107

    Google Scholar 

  32. Llovet JM (2005) Updated treatment approach to heoatocellular carcinoma. J Gastroenterol (40):225–235

    Article  PubMed  Google Scholar 

  33. Crissien AM, Frenette C (2014) Current management of hepatocellular carcinoma. Gastroenterol Hepatol (NY) 10(3):153–161

    Google Scholar 

  34. Otto G, Heise M, Moench C et al (2007) Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma. Transplant Proc 39(2):537–539

    Article  CAS  PubMed  Google Scholar 

  35. Vogel TJ, Zangos S, Balzer JO et al (2007) Transarterielle Chemoembolisation (TACE) des hepatozellulären Karzinoms: Technik, Indikationsstellung und Ergebnisse. Röfo 179:1–14

    Google Scholar 

  36. Iyengar P, Westover K, Timmerman RD (2013) Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer. Semin Respir Crit Care Med 34(6):845–854

    Article  PubMed  Google Scholar 

  37. Napoli A, Anzidei M, De Nunzio C et al (2013) Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. Eur Urol 63(2):395–398

    Article  PubMed  Google Scholar 

  38. Hurwitz MD, Ghanouni P, Kanaev SV et al (2014) Magnetic resonance-guided focused ultrasound for patients with painful metastases: phase III trial results. J Natl Cancer Institute 106(5):pii: dju 082

    Article  Google Scholar 

  39. Llovet JM, Di Bisceglie AD, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100(10):698–711

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Radiologie, Krankenhaus der Augustinerinnen Köln, Jakobstr. 27-31, 50678, Köln, Deutschland

    F. Schellhammer

  2. Klinik für Allgemein-, Viszeral- und Unfallchirurgie, Krankenhaus der Augustinerinnen Köln, Jakobstr. 27-31, 50678, Köln, Deutschland

    T. Beckurts

  3. Klinik für Innere Medizin, Bereiche Gastroenterologie, Infektiologie, Krankenhaus der Augustinerinnen Köln, Jakobstr. 27-31, 50678, Köln, Deutschland

    M. Oette

Authors
  1. F. Schellhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Beckurts
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Oette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Schellhammer.

Additional information

Einhaltung ethischer Richtlinien

Interessenkonflikt. F. Schellhammer, T. Beckurts und M. Oette geben an, dass keine Interessenkonflikte bestehen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schellhammer, F., Beckurts, T. & Oette, M. Bildgesteuerte, minimalinvasive Verfahren in der Onkologie. best practice onkologie 10, 6–12 (2015). https://doi.org/10.1007/s11654-014-0518-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11654-014-0518-x

Search

Navigation